Hepatitis B Virus Associated Hepatocarcinoma Activated Unique Metabolism Pathway to Gain Survival Advantages

Yingke Zhao,Zhouyu Ning,Yong Deng,Bing Li,Yun Sun,Zhiqiang Meng

DOI: https://doi.org/10.21203/rs.3.rs-1037759/v1

2021-01-01

Abstract:Abstract Background: Hepatitis B Virus (HBV) is considered as a “metabolic virus” and affects the hepatic metabolism homeostasis, while except for the anti-virus therapy the principle of HBV-negtive hepatocellular carcinoma (HCC) and HBV-positive HCC is exactly the same until now. Exploration of the unique characteristics of HBV-associated HCC will provide new metabolic targets against HBV-associated HCC to gain survial advantage, and finally inhibit cancer progression. Methods: To systematically assess the metabolic changes, we assessed the transcriptomic and proteomic data from public database, additionally verified the accordingly changes in our own test cohort on proteome and transcriptome level. Additionally, the tissue metabolomics profile, lipidomics and the activity of PI3K/AKT/mTOR signaling pathway which play critical role in metabolism reprogramming, were analyzed to confirm the aforementioned changes. Results: By multi-omics approaches, we presented the metabolic dysfunction experienced during HBV-associated HCC, represented by upregulated the steroid hormone biosynthesis, primary bile acid, and sphingolipid metabolism which related to a poor prognosis. Metabolites in linoleic acid metabolism and primary bile acid metabolism were closely correlated with HBV replication in HBV-positive HCC patients. Further tissue metabolomics and lipidomics validate the serum metabolic changes, namely changing in lipid composition and unsaturated fatty acid accumulation. By antibody array, a hyperactive PI3K/AKT/mTOR signaling transduction in HBV-positive biopsy compared with HBV-negative patients was observed, indicating a key role of this pathway in metabolic reprogramming of HBV-associate HCC. Conclusion: HBV plays a critical role in the metabolism of HBV-associated HCC and activated a unique metabolism pathway to gain survival advantages. HBV-positive HCC showed obviously difference compared to HBV-negative HCC in metabolism at least and should be treated according to its characteristics in the clinic.